|
|
|
|
|
|
|
|
Public Meeting on Neuropathic Pain Associated with Peripheral Neuropathy Patient-Focused Drug Development
On June 10, 2016, FDA is conducting a public meeting on
Patient-Focused Drug Development for Neuropathic Pain associated with
Peripheral Neuropathy. FDA is interested in obtaining patient input on
the impact of Neuropathic Pain associated with Peripheral Neuropathy on
daily life and patients’ views on currently available therapies to treat
the condition.
This website will be updated as meeting materials are developed.
This website will be updated as meeting materials are developed.
Date:
June 10, 2016
Time:
1:00 p.m. - 5:00 p.m.
Location:
FDA White Oak Campus
10903 New Hampshire Ave.
Building 31, Room 1503A (Great Room)
Silver Spring, MD 20993
(Information about arrival to FDA’s White Oak campus)
10903 New Hampshire Ave.
Building 31, Room 1503A (Great Room)
Silver Spring, MD 20993
(Information about arrival to FDA’s White Oak campus)
Registration:
To register for this meeting, visit: http://peripheralneuropathypfdd.eventbrite.com
Registration to attend the meeting must be received by June 3, 2016.
Webcast Information:
Please use this link to join the Adobe Connect webcast room: Webcast
The link will begin working one hour before the start of the meeting. We recommend joining the webcast at least 15 minutes early to allow for any technical issues.
The link will begin working one hour before the start of the meeting. We recommend joining the webcast at least 15 minutes early to allow for any technical issues.
Submitting Comments to the Public Docket:
In addition to providing input at the public meeting, patient
stakeholders are invited to provide their perspectives on the discussion
questions through the public docket. The docket closes on June 10,
2016.
- FDA is interested in patient responses to the questions listed in the Federal Register Notice. There are also Spanish translated questions available below, under "Meeting Materials."
- Visit the Public Docket to submit your comment......
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.